ES2692644T3 - Dispersiones acuosas de polímeros de liberación controlada y cubiertas y cápsulas para las mismas - Google Patents
Dispersiones acuosas de polímeros de liberación controlada y cubiertas y cápsulas para las mismas Download PDFInfo
- Publication number
- ES2692644T3 ES2692644T3 ES13711002.9T ES13711002T ES2692644T3 ES 2692644 T3 ES2692644 T3 ES 2692644T3 ES 13711002 T ES13711002 T ES 13711002T ES 2692644 T3 ES2692644 T3 ES 2692644T3
- Authority
- ES
- Spain
- Prior art keywords
- rpm
- weight
- aqueous composition
- capsule
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 105
- 239000006185 dispersion Substances 0.000 title claims abstract description 99
- 239000002775 capsule Substances 0.000 title claims description 151
- 238000013270 controlled release Methods 0.000 title description 36
- 239000000203 mixture Substances 0.000 claims abstract description 166
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 83
- 238000000034 method Methods 0.000 claims abstract description 78
- 238000004519 manufacturing process Methods 0.000 claims abstract description 56
- 239000007902 hard capsule Substances 0.000 claims abstract description 49
- 230000008569 process Effects 0.000 claims abstract description 45
- 238000007654 immersion Methods 0.000 claims abstract description 40
- 238000000465 moulding Methods 0.000 claims abstract description 34
- 239000006057 Non-nutritive feed additive Substances 0.000 claims abstract description 29
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims abstract description 18
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims abstract description 18
- 238000001035 drying Methods 0.000 claims abstract description 18
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 15
- 229920001002 functional polymer Polymers 0.000 claims abstract description 12
- 239000007901 soft capsule Substances 0.000 claims description 23
- 239000004480 active ingredient Substances 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 6
- -1 polyoxyethylene Polymers 0.000 abstract description 12
- 239000010408 film Substances 0.000 description 76
- 239000000243 solution Substances 0.000 description 66
- ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 description 65
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 description 63
- 239000000725 suspension Substances 0.000 description 58
- 238000003760 magnetic stirring Methods 0.000 description 52
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 44
- 238000003756 stirring Methods 0.000 description 43
- 229920001983 poloxamer Polymers 0.000 description 36
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 32
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 32
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 32
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 32
- 238000009472 formulation Methods 0.000 description 31
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 31
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 29
- 229920003119 EUDRAGIT E PO Polymers 0.000 description 28
- NEDGUIRITORSKL-UHFFFAOYSA-N butyl 2-methylprop-2-enoate;2-(dimethylamino)ethyl 2-methylprop-2-enoate;methyl 2-methylprop-2-enoate Chemical compound COC(=O)C(C)=C.CCCCOC(=O)C(C)=C.CN(C)CCOC(=O)C(C)=C NEDGUIRITORSKL-UHFFFAOYSA-N 0.000 description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- 238000012360 testing method Methods 0.000 description 24
- 235000010215 titanium dioxide Nutrition 0.000 description 22
- 238000013019 agitation Methods 0.000 description 15
- 238000004090 dissolution Methods 0.000 description 15
- 229960000502 poloxamer Drugs 0.000 description 15
- 239000004408 titanium dioxide Substances 0.000 description 15
- 238000000265 homogenisation Methods 0.000 description 14
- 239000002245 particle Substances 0.000 description 13
- 239000008213 purified water Substances 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 238000011156 evaluation Methods 0.000 description 12
- 239000012530 fluid Substances 0.000 description 12
- 239000010410 layer Substances 0.000 description 12
- 229920002507 Poloxamer 124 Polymers 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- 230000035800 maturation Effects 0.000 description 10
- 239000004014 plasticizer Substances 0.000 description 10
- 229940093448 poloxamer 124 Drugs 0.000 description 10
- 238000007789 sealing Methods 0.000 description 10
- 229910001220 stainless steel Inorganic materials 0.000 description 10
- 239000010935 stainless steel Substances 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 230000002496 gastric effect Effects 0.000 description 9
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 230000005070 ripening Effects 0.000 description 9
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 8
- 108010010803 Gelatin Proteins 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 8
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 8
- 239000008273 gelatin Substances 0.000 description 8
- 229920000159 gelatin Polymers 0.000 description 8
- 235000019322 gelatine Nutrition 0.000 description 8
- 235000011852 gelatine desserts Nutrition 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 239000001069 triethyl citrate Substances 0.000 description 8
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 8
- 235000013769 triethyl citrate Nutrition 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 229960005489 paracetamol Drugs 0.000 description 7
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 239000000576 food coloring agent Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229920000056 polyoxyethylene ether Polymers 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 238000004581 coalescence Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 5
- 229920000053 polysorbate 80 Polymers 0.000 description 5
- 239000011118 polyvinyl acetate Substances 0.000 description 5
- 229920002689 polyvinyl acetate Polymers 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 229920001661 Chitosan Polymers 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 239000008186 active pharmaceutical agent Substances 0.000 description 4
- 239000003125 aqueous solvent Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000005266 casting Methods 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 238000005189 flocculation Methods 0.000 description 4
- 230000016615 flocculation Effects 0.000 description 4
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 4
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 229920000609 methyl cellulose Polymers 0.000 description 4
- 239000001923 methylcellulose Substances 0.000 description 4
- 235000010981 methylcellulose Nutrition 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 229920001993 poloxamer 188 Polymers 0.000 description 4
- 229920006254 polymer film Polymers 0.000 description 4
- 229920000193 polymethacrylate Polymers 0.000 description 4
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 150000001767 cationic compounds Chemical class 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- LUJQXGBDWAGQHS-UHFFFAOYSA-N ethenyl acetate;phthalic acid Chemical compound CC(=O)OC=C.OC(=O)C1=CC=CC=C1C(O)=O LUJQXGBDWAGQHS-UHFFFAOYSA-N 0.000 description 3
- 229920001249 ethyl cellulose Polymers 0.000 description 3
- 235000019325 ethyl cellulose Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 238000001879 gelation Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N Indigo Chemical compound N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000008118 PEG 6000 Substances 0.000 description 2
- 229920002023 Pluronic® F 87 Polymers 0.000 description 2
- 229920002043 Pluronic® L 35 Polymers 0.000 description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical class CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
- 229920013820 alkyl cellulose Polymers 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 2
- 239000001639 calcium acetate Substances 0.000 description 2
- 229960005147 calcium acetate Drugs 0.000 description 2
- 235000011092 calcium acetate Nutrition 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000005056 compaction Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 239000002702 enteric coating Substances 0.000 description 2
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical compound OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 125000005908 glyceryl ester group Chemical group 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000003605 opacifier Substances 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 2
- 229940044519 poloxamer 188 Drugs 0.000 description 2
- 229920001992 poloxamer 407 Polymers 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920002744 polyvinyl acetate phthalate Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 2
- 229940066675 ricinoleate Drugs 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 1
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 229920003134 Eudragit® polymer Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 101000748141 Homo sapiens Ubiquitin carboxyl-terminal hydrolase 32 Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 102100040050 Ubiquitin carboxyl-terminal hydrolase 32 Human genes 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- SXQXMCWCWVCFPC-UHFFFAOYSA-N aluminum;potassium;dioxido(oxo)silane Chemical compound [Al+3].[K+].[O-][Si]([O-])=O.[O-][Si]([O-])=O SXQXMCWCWVCFPC-UHFFFAOYSA-N 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000029618 autoimmune pulmonary alveolar proteinosis Diseases 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- WXLFIFHRGFOVCD-UHFFFAOYSA-L azophloxine Chemical compound [Na+].[Na+].OC1=C2C(NC(=O)C)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 WXLFIFHRGFOVCD-UHFFFAOYSA-L 0.000 description 1
- 235000012733 azorubine Nutrition 0.000 description 1
- TVWOWDDBXAFQDG-DQRAZIAOSA-N azorubine Chemical compound C1=CC=C2C(\N=N/C3=C(C4=CC=CC=C4C(=C3)S(O)(=O)=O)O)=CC=C(S(O)(=O)=O)C2=C1 TVWOWDDBXAFQDG-DQRAZIAOSA-N 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000012709 brilliant black BN Nutrition 0.000 description 1
- 239000004126 brilliant black BN Substances 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- DGQLVPJVXFOQEV-JNVSTXMASA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-JNVSTXMASA-N 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 1
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 235000019805 chlorophyllin Nutrition 0.000 description 1
- 229940099898 chlorophyllin Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- PCYQQSKDZQTOQG-NXEZZACHSA-N dibutyl (2r,3r)-2,3-dihydroxybutanedioate Chemical compound CCCCOC(=O)[C@H](O)[C@@H](O)C(=O)OCCCC PCYQQSKDZQTOQG-NXEZZACHSA-N 0.000 description 1
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical group CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- NIQCNGHVCWTJSM-UHFFFAOYSA-N dimethyl benzenedicarboxylate Natural products COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229910001411 inorganic cation Inorganic materials 0.000 description 1
- 235000014413 iron hydroxide Nutrition 0.000 description 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical class [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 1
- 125000002669 linoleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- GVKCHTBDSMQENH-UHFFFAOYSA-L phloxine B Chemical compound [Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 GVKCHTBDSMQENH-UHFFFAOYSA-L 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- FLKPEMZONWLCSK-UHFFFAOYSA-N phthalic acid di-n-ethyl ester Natural products CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 1
- MQHNKCZKNAJROC-UHFFFAOYSA-N phthalic acid dipropyl ester Natural products CCCOC(=O)C1=CC=CC=C1C(=O)OCCC MQHNKCZKNAJROC-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229940100467 polyvinyl acetate phthalate Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000012731 ponceau 4R Nutrition 0.000 description 1
- 239000004175 ponceau 4R Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 235000012739 red 2G Nutrition 0.000 description 1
- 239000004180 red 2G Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- GMMAPXRGRVJYJY-UHFFFAOYSA-J tetrasodium 4-acetamido-5-hydroxy-6-[[7-sulfonato-4-[(4-sulfonatophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1,7-disulfonate Chemical compound [Na+].[Na+].[Na+].[Na+].OC1=C2C(NC(=O)C)=CC=C(S([O-])(=O)=O)C2=CC(S([O-])(=O)=O)=C1N=NC(C1=CC(=CC=C11)S([O-])(=O)=O)=CC=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 GMMAPXRGRVJYJY-UHFFFAOYSA-J 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 229940001496 tribasic sodium phosphate Drugs 0.000 description 1
- DQWPFSLDHJDLRL-UHFFFAOYSA-N triethyl phosphate Chemical compound CCOP(=O)(OCC)OCC DQWPFSLDHJDLRL-UHFFFAOYSA-N 0.000 description 1
- AAAQKTZKLRYKHR-UHFFFAOYSA-N triphenylmethane Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 AAAQKTZKLRYKHR-UHFFFAOYSA-N 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 239000010693 vegetable lubricating oil Substances 0.000 description 1
- 125000002348 vinylic group Chemical group 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
- B29C41/02—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
- B29C41/14—Dipping a core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
- A61J3/077—Manufacturing capsule shells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/712—Containers; Packaging elements or accessories, Packages
- B29L2031/7174—Capsules
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mechanical Engineering (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261641505P | 2012-05-02 | 2012-05-02 | |
| US201261641485P | 2012-05-02 | 2012-05-02 | |
| US201261641485P | 2012-05-02 | ||
| US201261641505P | 2012-05-02 | ||
| PCT/EP2013/055302 WO2013164122A1 (en) | 2012-05-02 | 2013-03-14 | Aqueous dispersions of controlled release polymers and shells and capsules thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2692644T3 true ES2692644T3 (es) | 2018-12-04 |
Family
ID=47884337
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13711002.9T Active ES2692644T3 (es) | 2012-05-02 | 2013-03-14 | Dispersiones acuosas de polímeros de liberación controlada y cubiertas y cápsulas para las mismas |
| ES13709435T Active ES2728850T3 (es) | 2012-05-02 | 2013-03-14 | Dispersiones acuosas de acetato acetato succinato de hidroxipropilmetilcelulosa (HPMCAS) |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13709435T Active ES2728850T3 (es) | 2012-05-02 | 2013-03-14 | Dispersiones acuosas de acetato acetato succinato de hidroxipropilmetilcelulosa (HPMCAS) |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US10525010B2 (https=) |
| EP (4) | EP2844296B1 (https=) |
| JP (3) | JP6626712B2 (https=) |
| CA (2) | CA2870134C (https=) |
| ES (2) | ES2692644T3 (https=) |
| WO (2) | WO2013164122A1 (https=) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2870134C (en) | 2012-05-02 | 2020-04-28 | Capsugel France SAS | Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas) |
| KR102138545B1 (ko) | 2012-08-24 | 2020-07-28 | 다우 글로벌 테크놀로지스 엘엘씨 | 고분자량 및 높은 균일성을 갖는 신규한 에스테르화된 셀룰로즈 에테르 |
| US20160256399A1 (en) | 2013-11-04 | 2016-09-08 | Capsugel Belgium Nv | Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole |
| JP6254719B2 (ja) * | 2014-04-08 | 2017-12-27 | ダウ グローバル テクノロジーズ エルエルシー | エステル化セルロースエーテルを含む分散体 |
| ES2793530T3 (es) * | 2014-05-19 | 2020-11-16 | Tillotts Pharma Ag | Cápsulas revestidas de liberación modificada |
| WO2015179072A1 (en) | 2014-05-20 | 2015-11-26 | Dow Global Technologies Llc | Dispersion comprising a partially neutralized esterified cellulose ether |
| CN106456555B (zh) * | 2014-05-20 | 2019-05-07 | 陶氏环球技术有限责任公司 | 包含酯化纤维素醚的胶囊壳 |
| CN104055750B (zh) * | 2014-07-03 | 2016-09-21 | 王荣辉 | 具有靶向功能的空心胶囊及制备方法 |
| JP6722657B2 (ja) | 2014-08-20 | 2020-07-15 | スリーエム イノベイティブ プロパティズ カンパニー | 試料の分割及び分析のためのデバイス及び方法 |
| JP6865159B2 (ja) * | 2014-08-20 | 2021-04-28 | スリーエム イノベイティブ プロパティズ カンパニー | 硫酸塩還元微生物用の内蔵型嫌気性培養デバイス |
| WO2016030234A1 (en) | 2014-08-29 | 2016-03-03 | Capsugel Belgium N.V. | Colloidal dispersion comprising hpmcas |
| US10471152B2 (en) | 2014-08-29 | 2019-11-12 | Capsugel Belgium Nv | Colloidal dispersion comprising HPMCAS |
| EP3236993B1 (en) | 2014-12-23 | 2023-09-13 | Theriva Biologics, Inc. | Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics |
| US10377835B2 (en) | 2015-03-16 | 2019-08-13 | Dow Global Technologies Llc | Water-soluble esterified cellulose ethers |
| EP3270970B1 (en) | 2015-03-16 | 2019-01-09 | Dow Global Technologies LLC | Gelling esterified cellulose ethers |
| MX2017011096A (es) | 2015-03-16 | 2017-11-10 | Dow Global Technologies Llc | Solucion acuosa de un eter de celulosa esterificado. |
| US10214594B2 (en) | 2015-03-16 | 2019-02-26 | Dow Global Technologies Llc | Water-soluble esterified cellulose ethers having a low degree of neutralization |
| US20160331689A1 (en) * | 2015-05-12 | 2016-11-17 | SE Tylose USA, Inc. | Aqueous enteric coating composition |
| WO2017019276A1 (en) | 2015-07-28 | 2017-02-02 | Dow Global Technologies Llc | Process for producing dispersion of esterified cellulose ether |
| WO2017048618A1 (en) | 2015-09-16 | 2017-03-23 | Dow Global Technologies Llc | Water-redispersible polymer powder |
| WO2017052301A1 (ko) * | 2015-09-25 | 2017-03-30 | 롯데정밀화학 주식회사 | 하이드로겔 시트용 조성물, 이로부터 제조되는 하이드로겔 시트 및 이의 제조 방법 |
| CN108026184B (zh) * | 2015-10-02 | 2020-09-15 | 陶氏环球技术有限责任公司 | 包含分散的酯化纤维素醚的水性组合物 |
| KR102435660B1 (ko) * | 2015-11-06 | 2022-08-24 | 롯데정밀화학 주식회사 | 건조 하이드로겔 시트의 제조방법 및 그 제조방법에 의해 제조된 건조 하이드로겔 시트 |
| BR112018010354A2 (pt) * | 2015-12-08 | 2018-12-04 | Dow Global Technologies Llc | composições compreendendo éteres de celulose e éteres de celulose esterificados solúveis em água |
| EP3199148B1 (en) * | 2016-01-28 | 2020-12-02 | Capsugel Belgium NV | Compositions and resulting hard capsules comprising hydrophilic coloring foodstuff concentrates |
| WO2017146853A1 (en) * | 2016-02-24 | 2017-08-31 | Dow Global Technologies Llc | Aqueous composition comprising water-soluble esterified cellulose ethers |
| PL239878B1 (pl) * | 2016-03-30 | 2022-01-24 | Gdanski Univ Medyczny | Wodna kompozycja oraz sposób wytwarzania dojelitowych elastycznych filmów do sporządzania kapsułek z wodnej kompozycji oraz dojelitowy elastyczny film do sporządzania kapsułek miękkich |
| JP6683561B2 (ja) | 2016-07-12 | 2020-04-22 | 信越化学工業株式会社 | 腸溶性硬カプセル用組成物及び腸溶性硬カプセルの製造方法 |
| EP3272340A1 (en) * | 2016-07-22 | 2018-01-24 | Capsugel Belgium NV | Acid resistant capsules |
| KR20180062784A (ko) * | 2016-12-01 | 2018-06-11 | 롯데정밀화학 주식회사 | 경질캡슐의 제조방법 및 이로부터 제조되는 경질캡슐 |
| WO2018175648A1 (en) * | 2017-03-21 | 2018-09-27 | Bioduro, Llc | Gastrointestinal-protective formulations for oral delivery of proteins and peptides |
| JP7198205B2 (ja) | 2017-07-11 | 2022-12-28 | クオリカプス株式会社 | 腸溶性硬質カプセル |
| CO2017007322A1 (es) * | 2017-07-24 | 2019-01-31 | Novamed S A | Cápsulas duras resistentes al ácido con bajo contenido de coadyuvantes de gelificacion |
| WO2019032573A1 (en) | 2017-08-07 | 2019-02-14 | Finch Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER |
| CA3087569A1 (en) | 2018-01-09 | 2019-07-18 | Synthetic Biologics, Inc. | Alkaline phosphatase agents for treatment of neurodevelopmental disorders |
| KR102086461B1 (ko) * | 2018-01-19 | 2020-03-09 | 주식회사 서흥 | 열겔화 히프로멜로오스 하드 캡슐의 제조방법 |
| BR112020017090A8 (pt) | 2018-02-23 | 2022-07-05 | Crestovo Holdings Llc | Imunoterapias relacionadas com microbioma |
| US11980691B2 (en) | 2018-03-15 | 2024-05-14 | R.P. Scherer Technologies, Llc | Enteric softgel capsules |
| WO2019183208A1 (en) | 2018-03-20 | 2019-09-26 | Synthetic Biologics, Inc. | Intestinal alkaline phosphatase formulations |
| EP4275761A3 (en) | 2018-03-20 | 2024-02-28 | Theriva Biologics, Inc. | Alkaline phosphatase agents for treatment of radiation disorders |
| ES2895161T3 (es) | 2018-05-14 | 2022-02-17 | Capsugel Belgium Nv | Cápsulas con opacificante |
| BR112020026058A2 (pt) | 2018-06-22 | 2021-04-13 | Qualicaps Co., Ltd. | Cápsula entérica dura |
| EP3829644A4 (en) * | 2018-07-30 | 2022-05-04 | Ricoh Company, Ltd. | PROCESS FOR MANUFACTURING PARTICLES AND PARTICLE AND MEDICATION MANUFACTURED BY THE PROCESS |
| JP7503781B2 (ja) * | 2018-07-30 | 2024-06-21 | 株式会社リコー | 粒子の製造方法、並びに、それにより製造された粒子及び医薬 |
| WO2020131801A1 (en) | 2018-12-18 | 2020-06-25 | DDP Specialty Electronic Materials US, Inc. | A sustained release composition comprising a hydroxypropyl methylcellulose acetate succinate |
| EP3937909B1 (en) | 2019-03-14 | 2026-03-04 | Evonik Operations GmbH | Capsule shell comprising a core-shell polymer and a cellulose |
| BR112021022194A2 (pt) | 2019-05-07 | 2021-12-28 | Bausch Health Ireland Ltd | Formulações líquidas para dosagem oral de metilnaltrexona |
| CA3146738A1 (en) | 2019-07-18 | 2021-01-21 | Synthetic Biologics, Inc. | Intestinal alkaline phosphatase-based treatments of metabolic disorders |
| US12290538B2 (en) | 2019-07-19 | 2025-05-06 | Finch Therapeutics Holdings Llc | Methods and products for treatment of gastrointestinal disorders |
| CN110507629B (zh) * | 2019-09-02 | 2021-02-23 | 广东广发制药有限公司 | 一种植物纤维素软胶囊胶皮及其制备方法 |
| CN114650833A (zh) | 2019-09-13 | 2022-06-21 | 芬奇治疗控股有限责任公司 | 用于治疗孤独症谱群障碍的组合物和方法 |
| CA3153328A1 (en) * | 2019-10-16 | 2021-04-22 | Aouatef Bellamine | Method and composition for increasing muscle protein synthesis |
| AU2020366529A1 (en) | 2019-10-18 | 2022-05-19 | Finch Therapeutics Holdings Llc | Compositions and methods for delivering a bacterial metabolite to a subject |
| WO2021097288A1 (en) | 2019-11-15 | 2021-05-20 | Finch Therapeutics Holdings Llc | Compositions and methods for treating neurodegenerative diseases |
| US12552951B2 (en) * | 2019-12-17 | 2026-02-17 | Agfa Nv | Aqueous dispersion of polymeric capsules |
| WO2021142358A1 (en) | 2020-01-10 | 2021-07-15 | Finch Therapeutics Holdings Llc | Compositions and methods for treating hepatic encephalopathy (he) |
| WO2021142347A1 (en) | 2020-01-10 | 2021-07-15 | Finch Therapeutics Holdings Llc | Compositions and methods for non-alcoholic steatohepatitis (nash) |
| TW202140049A (zh) | 2020-01-10 | 2021-11-01 | 美商芬奇治療控股有限責任公司 | 用於治療ｂ型肝炎（ｈｂｖ）及ｄ型肝炎（ｈｄｖ）之組合物及方法 |
| WO2021202806A1 (en) | 2020-03-31 | 2021-10-07 | Finch Therapeutics Holdings Llc | Compositions comprising non-viable fecal microbiota and methods of use thereof |
| CA3177250A1 (en) | 2020-05-02 | 2021-11-11 | Bausch Health Ireland Limited | Methods of reducing mortality risk in subjects suffering from an underlying disease or condition by administration of methylnaltrexone |
| JP2023553309A (ja) * | 2020-11-25 | 2023-12-21 | キャプシュゲル・ベルジウム・エヌ・ヴィ | 二重層遅延放出硬質カプセル |
| WO2022115681A2 (en) * | 2020-11-30 | 2022-06-02 | Romeg Therapeutics Llc | Methods and compositions for oral pilocarpine liquid |
| US20240263251A1 (en) | 2021-02-19 | 2024-08-08 | Finch Therapeutics Holdings Llc | Compositions and methods for providing secondary bile acids to a subject |
| JP7833456B2 (ja) * | 2021-05-18 | 2026-03-19 | キャプシュゲル・ベルジウム・エヌ・ヴィ | 非ゼラチン硬カプセル及びその製造方法 |
| JP2025519816A (ja) | 2022-06-21 | 2025-06-26 | ニュートリション アンド バイオサイエンシズ ユーエスエー １，リミティド ライアビリティ カンパニー | 硬質シェルカプセル、フィルム及びコーティングのためのフィルム形成遅延／腸溶配合物 |
Family Cites Families (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US338818A (en) * | 1886-03-30 | Picket-fence | ||
| GB643853A (en) | 1946-04-13 | 1950-09-27 | Lilly Co Eli | Medicinal capsules and process of manufacture |
| US2718667A (en) | 1952-05-01 | 1955-09-27 | Eastman Kodak Co | Method of preparing enteric capsules |
| GB1144225A (en) | 1965-09-07 | 1969-03-05 | Dow Chemical Co | Preparation of medicinal capsule shells from hydroxyalkyl-alkyl cellulose ethers |
| US3740421A (en) | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
| US3617588A (en) | 1969-06-16 | 1971-11-02 | Dow Chemical Co | Dip-coating process for preparing cellulose ether capsule shells |
| CA944689A (en) * | 1970-07-28 | 1974-04-02 | Claude Rene | Capsules en matieres plastiques et leurs procedes de fabrication |
| US4001211A (en) | 1974-12-02 | 1977-01-04 | The Dow Chemical Company | Pharmaceutical capsules from improved thermogelling methyl cellulose ethers |
| US4138013A (en) | 1976-08-27 | 1979-02-06 | Parke, Davis & Company | Enteric capsules |
| US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
| JPH027925B2 (https=) | 1978-10-02 | 1990-02-21 | Purdue Research Foundation | |
| JPS5890428A (ja) | 1981-11-17 | 1983-05-30 | Hitachi Denshi Ltd | 自動組立装置 |
| JPS58138458A (ja) | 1982-02-10 | 1983-08-17 | 信越化学工業株式会社 | 腸溶性カプセルの製造方法 |
| DE3222476A1 (de) | 1982-06-15 | 1983-12-15 | Warner-Lambert Co., 07950 Morris Plains, N.J. | Magensaftresistente weichgelatinekapseln und verfahren zu ihrer herstellung |
| US4656066A (en) | 1982-12-20 | 1987-04-07 | Warner-Lambert Company | Apparatus and method for sealing capsules |
| US4539060A (en) | 1983-02-18 | 1985-09-03 | Warner-Lambert Company | Apparatus and method of sealing capsules |
| JPS6114584U (ja) | 1984-06-28 | 1986-01-28 | 株式会社 宮川製作所 | 電話回線ル−プ電流瞬断防止装置 |
| JPS62104593A (ja) | 1985-10-31 | 1987-05-15 | Terumo Corp | アミノ酸脱炭酸能検査用培地組成物 |
| EP0352800A3 (en) * | 1988-07-28 | 1991-05-08 | Warner-Lambert Company | Aqueous polymeric dispersion of cellulosic and acrylic based polymers for preparing pharmaceutical dosage forms and dosage forms thereof |
| JPH0347246A (ja) | 1989-04-13 | 1991-02-28 | Olympus Optical Co Ltd | 内視鏡用処置具 |
| JPH0634807B2 (ja) | 1989-06-08 | 1994-05-11 | 信越化学工業株式会社 | 医薬用硬質カプセルの製造方法 |
| JP2552937B2 (ja) | 1990-03-29 | 1996-11-13 | 日本エランコ株式会社 | 医薬用硬質カプセルおよびその製造方法 |
| US5264223A (en) | 1990-03-29 | 1993-11-23 | Japan Elanco Company, Ltd. | Hard capsule for pharmaceutical drugs and method for producing the same |
| US5273760A (en) * | 1991-12-24 | 1993-12-28 | Euroceltigue, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| JP3839467B2 (ja) | 1992-06-04 | 2006-11-01 | スミスクライン・ビーチャム・コーポレイション | 味の良い医薬組成物 |
| JP3017906B2 (ja) * | 1993-10-08 | 2000-03-13 | 信越化学工業株式会社 | 腸溶性コーティング剤分散液 |
| US5508276A (en) * | 1994-07-18 | 1996-04-16 | Eli Lilly And Company | Duloxetine enteric pellets |
| US5756123A (en) | 1994-12-01 | 1998-05-26 | Japan Elanco Co., Ltd. | Capsule shell |
| AU4367396A (en) * | 1994-12-05 | 1996-06-26 | Permethyl Specialties L.L.C. | Water soluble, biodegradable polymeric materials for skin care, hair care and cosmetic applications |
| US5851579A (en) * | 1996-10-28 | 1998-12-22 | Eastman Chemical Company | Aqueous enteric coating compositions |
| US5910319A (en) * | 1997-05-29 | 1999-06-08 | Eli Lilly And Company | Fluoxetine enteric pellets and methods for their preparation and use |
| JP5068401B2 (ja) | 1998-09-28 | 2012-11-07 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ | Ｈｐｍｃカプセルを使用する腸及び結腸への送達 |
| DE19901686A1 (de) | 1999-01-18 | 2000-07-20 | Gruenenthal Gmbh | Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung |
| US6515008B1 (en) * | 2000-05-04 | 2003-02-04 | Smithkline Beecham Corporation | Formulation |
| SE0100200D0 (sv) * | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
| EP1262174A1 (en) | 2001-06-01 | 2002-12-04 | Celanese Ventures GmbH | Two part hard shell capsule made of poly(1,4-alpha-D-glucane) and starch |
| KR100461566B1 (ko) | 2001-11-15 | 2004-12-14 | 삼성정밀화학 주식회사 | 수계 분산 히드록시프로필메틸 셀룰로오스 프탈레이트나노입자의 제조방법 |
| KR20100047349A (ko) | 2001-11-22 | 2010-05-07 | 모리시타 진탄 가부시키가이샤 | 비젤라틴계 캡슐 피막 조성물 및 이를 이용한 캡슐 |
| FR2829142B1 (fr) * | 2001-12-27 | 2004-02-13 | Ulice | Composition filmogene d'heteroxylanes pour la fabrication de capsules ainsi obtenues |
| AU2003274683A1 (en) | 2002-08-02 | 2004-02-23 | Scitech Centre | NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS. |
| US7429619B2 (en) * | 2002-08-02 | 2008-09-30 | Mcneil Consumer Healthcare | Polyacrylic film forming compositions |
| ES2500316T3 (es) | 2002-10-01 | 2014-09-30 | Banner Pharmacaps, Inc. | Composición entérica para la fabricación de una cubierta de cápsula blanda |
| KR100483072B1 (ko) | 2003-11-26 | 2005-04-14 | 박현진 | 하드 캅셀에 적합한 필름 형성 조성물 및 이의 제조방법 |
| TW200520790A (en) | 2003-12-22 | 2005-07-01 | Dah Feng Capsule Industry Co Ltd | The compositions of a vegetarian capsule shell |
| US20070298095A1 (en) * | 2004-05-24 | 2007-12-27 | Shionogi Qualicaps Co., Ltd. | Surface-Modified and Solubility-Improved Hard Capsule |
| JP2006016372A (ja) | 2004-07-05 | 2006-01-19 | Shionogi Qualicaps Co Ltd | 腸溶性硬カプセル剤 |
| WO2006082842A1 (ja) | 2005-02-03 | 2006-08-10 | Qualicaps Co., Ltd. | 溶解性が改善された硬カプセル |
| WO2006132398A1 (ja) | 2005-06-06 | 2006-12-14 | Ajinomoto Co., Inc. | カプセル皮膜用組成物 |
| US20070053869A1 (en) * | 2005-09-02 | 2007-03-08 | Yuichi Sugiyama | Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| US20070082046A1 (en) * | 2005-10-11 | 2007-04-12 | Banner Pharmacaps, Inc. | Enteric valproic acid |
| CN102488652B (zh) * | 2006-03-16 | 2014-06-18 | 特瑞斯制药股份有限公司 | 含有药物-离子交换树脂复合物的经修饰释放的制剂 |
| ES2360423T3 (es) | 2006-04-26 | 2011-06-03 | Supernus Pharmaceuticals, Inc. | Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal. |
| DE602007008470D1 (en) * | 2006-10-17 | 2010-09-23 | Bend Res Inc | Off |
| KR20120038021A (ko) * | 2006-10-27 | 2012-04-20 | 화이자 프로덕츠 인코포레이티드 | 하이드록시프로필 메틸 셀룰로스 경질 캡슐 및 이의 제조 방법 |
| GB0706178D0 (en) | 2007-03-29 | 2007-05-09 | Univ Aston | Enteric pharmaceutical capsules |
| US8105625B2 (en) | 2007-04-05 | 2012-01-31 | University Of Kansas | Rapidly dissolving pharmaceutical compositions comprising pullulan |
| JP5632282B2 (ja) * | 2007-08-02 | 2014-11-26 | ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ | Ｎ，ｎ−ジエチルアミノエチルメタクリラートをベースとする水性ポリマーディスパージョン、その調製及び使用 |
| US20090074944A1 (en) * | 2007-09-18 | 2009-03-19 | Viva Pharmaceuticals Inc. | Enteric coatings for orally ingestible compositions |
| JP5667874B2 (ja) | 2007-10-19 | 2015-02-12 | ファイザー・プロダクツ・インク | マルチコンパートメント容器 |
| WO2009063916A1 (ja) * | 2007-11-16 | 2009-05-22 | Asahi Kasei Chemicals Corporation | 水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤 |
| KR101235951B1 (ko) | 2008-05-12 | 2013-02-21 | 화이자 인코포레이티드 | 통기구를 구비한 개선된 캡슐 |
| US20100158997A1 (en) | 2008-12-18 | 2010-06-24 | Liang Chang Dong | Blow-molded thin-walled drug delivery capsules |
| US9107451B2 (en) | 2009-07-29 | 2015-08-18 | Evonik Röhm Gmbh | Coating composition for the dip coating of capsule halves |
| KR101705204B1 (ko) * | 2009-09-11 | 2017-02-09 | 롯데정밀화학 주식회사 | 장용성 경질 캡슐용 수성 조성물, 장용성 경질 캡슐의 제조방법 및 장용성 경질 캡슐 |
| DK2480218T3 (da) | 2009-09-24 | 2020-08-24 | Capsugel Belgium Nv | Syreresistente kapsler |
| KR101182827B1 (ko) | 2010-06-11 | 2012-09-14 | 삼성정밀화학 주식회사 | 장용성 경질 캡슐의 제조방법 및 장용성 경질 캡슐 |
| KR101787481B1 (ko) | 2010-10-21 | 2017-10-18 | 롯데정밀화학 주식회사 | 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐 |
| EP2722104B1 (en) * | 2010-10-26 | 2018-03-07 | Capsugel Belgium NV | Bulk Enteric Capsule Shells |
| EP2726053B1 (en) * | 2011-09-29 | 2018-10-24 | Union Carbide Chemicals & Plastics Technology LLC | Cationic conditioner replacements |
| WO2013150331A1 (en) * | 2011-11-09 | 2013-10-10 | Capsugel Belgium Nv | Acid resistant banding solution for acid resistant two piece hard capsules |
| CA2870134C (en) | 2012-05-02 | 2020-04-28 | Capsugel France SAS | Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas) |
| WO2015179072A1 (en) | 2014-05-20 | 2015-11-26 | Dow Global Technologies Llc | Dispersion comprising a partially neutralized esterified cellulose ether |
| US10471152B2 (en) | 2014-08-29 | 2019-11-12 | Capsugel Belgium Nv | Colloidal dispersion comprising HPMCAS |
| TWI587880B (zh) | 2015-03-24 | 2017-06-21 | Can be made into the composition of enteric capsule shell, enteric capsule shell and its process | |
| US9452141B1 (en) | 2015-05-01 | 2016-09-27 | Dah Feng Capsule Industry Co., Ltd. | Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process |
| EP3566699A1 (en) * | 2015-11-10 | 2019-11-13 | Capsugel Belgium NV | Acid resistant banding or sealing solution for acid resistant two piece hard capsules |
| US20170157058A1 (en) | 2015-12-08 | 2017-06-08 | Dah Feng Capsule Industry Co., Ltd. | Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process |
| EP3272340A1 (en) | 2016-07-22 | 2018-01-24 | Capsugel Belgium NV | Acid resistant capsules |
-
2013
- 2013-03-14 CA CA2870134A patent/CA2870134C/en not_active Expired - Fee Related
- 2013-03-14 WO PCT/EP2013/055302 patent/WO2013164122A1/en not_active Ceased
- 2013-03-14 ES ES13711002.9T patent/ES2692644T3/es active Active
- 2013-03-14 ES ES13709435T patent/ES2728850T3/es active Active
- 2013-03-14 JP JP2015509339A patent/JP6626712B2/ja not_active Expired - Fee Related
- 2013-03-14 EP EP13709435.5A patent/EP2844296B1/en not_active Not-in-force
- 2013-03-14 US US14/398,177 patent/US10525010B2/en not_active Expired - Fee Related
- 2013-03-14 EP EP19162194.5A patent/EP3524271A1/en not_active Withdrawn
- 2013-03-14 EP EP18188242.4A patent/EP3446713A3/en not_active Withdrawn
- 2013-03-14 WO PCT/EP2013/055298 patent/WO2013164121A1/en not_active Ceased
- 2013-03-14 JP JP2015509338A patent/JP6397813B2/ja not_active Expired - Fee Related
- 2013-03-14 EP EP13711002.9A patent/EP2844297B1/en not_active Not-in-force
- 2013-03-14 US US13/827,523 patent/US10463625B2/en not_active Expired - Fee Related
- 2013-03-14 CA CA2870033A patent/CA2870033C/en active Active
-
2017
- 2017-11-24 JP JP2017225773A patent/JP2018058870A/ja active Pending
-
2019
- 2019-10-22 US US16/660,714 patent/US10898440B2/en not_active Expired - Fee Related
-
2021
- 2021-01-04 US US17/141,156 patent/US20210196642A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2844296B1 (en) | 2019-03-13 |
| EP3524271A1 (en) | 2019-08-14 |
| US20150132372A1 (en) | 2015-05-14 |
| JP2015515962A (ja) | 2015-06-04 |
| US10525010B2 (en) | 2020-01-07 |
| EP3446713A3 (en) | 2019-05-15 |
| ES2728850T3 (es) | 2019-10-29 |
| EP2844296A1 (en) | 2015-03-11 |
| CA2870134A1 (en) | 2013-11-07 |
| JP2015518005A (ja) | 2015-06-25 |
| EP3446713A2 (en) | 2019-02-27 |
| US20130295188A1 (en) | 2013-11-07 |
| US20200054569A1 (en) | 2020-02-20 |
| JP6397813B2 (ja) | 2018-09-26 |
| CA2870033A1 (en) | 2013-11-07 |
| CA2870134C (en) | 2020-04-28 |
| US10898440B2 (en) | 2021-01-26 |
| EP2844297A1 (en) | 2015-03-11 |
| WO2013164121A4 (en) | 2014-01-30 |
| CA2870033C (en) | 2017-04-18 |
| WO2013164122A1 (en) | 2013-11-07 |
| JP6626712B2 (ja) | 2019-12-25 |
| EP2844297B1 (en) | 2018-08-15 |
| US10463625B2 (en) | 2019-11-05 |
| US20210196642A1 (en) | 2021-07-01 |
| WO2013164121A1 (en) | 2013-11-07 |
| JP2018058870A (ja) | 2018-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2692644T3 (es) | Dispersiones acuosas de polímeros de liberación controlada y cubiertas y cápsulas para las mismas | |
| ES2804779T3 (es) | Cápsulas resistentes a los ácidos | |
| US9198868B2 (en) | Bulk enteric capsule shells | |
| ES2726534T3 (es) | Disolución de precintado resistente a ácido para cápsulas duras de dos piezas resistentes a ácido | |
| JP5328768B2 (ja) | 硬質カプセル剤 | |
| HK40115670A (en) | Hard capsule, prepared solution for hard capsule, and method for preparing hard capsule | |
| EP4442255A1 (en) | Hard capsule, prepared solution for hard capsule, and method for preparing hard capsule |